Back to results
US 2017/0290846 A1Published application
In situ gelling form for long-acting drug delivery
AssigneeUniversity of Tennessee Research Foundation
InventorsTao L. Lowe, James Johnson, Linfeng Wu
Life of this patent
Estimating the term…
Abstract
The present invention relates to an injectable polymer matrix drug delivery system comprising a biodegradable polymer, a solvent or a combination of solvents, and an active pharmaceutical ingredient.
Claims26
An injectable polymer matrix drug delivery system comprising:
- a) a biodegradable polymer selected from the group consisting of polyester, poly(lactic-co-glycolic acid), poly(lactic acid), poly(ε-caprolactone), poly(ethylene glycol-block-lactic acid), poly(alkylcyanoacrylate), polyanhydride, poly(bis(p-carboxyphenoxy) propane-sebacic acid), polyorthoester, polyphosphoester, polyphosphazene, polyurethane, and poly(amino acid), or combinations thereof;
- b) a solvent or a combination of solvents;
- and
- c) an active pharmaceutical ingredient.
1 more element
Dependencies are inferred from the claim text.